Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

BACKGROUND: Methods to improve the clinical efficacy of currently available antibiotics against multidrug resistant bacteria in cystic fibrosis (CF) chronic rhinosinusitis (CRS) are greatly needed. Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, was recently identified...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Rhinol Allergy
Autors principals: Cho, Do-Yeon, Lim, Dong Jin, Mackey, Calvin, Skinner, Daniel, Zhang, Shaoyan, McCormick, Justin, Woodworth, Bradford A.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728449/
https://ncbi.nlm.nih.gov/pubmed/30585080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1945892418815615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars